Attention Deficit Hyperactivity Disorder
Conditions
Interventions
The duration of the neurofeedback treatment is 10 weeks. Participants receive
20 treatment sessions of 30 minutes, including EEG preparation. The treatment
is performed using the LENS Biofeedback sy
at a feedback frequency of 30
Hz, the actual duration of the feedback pulse is .003 seconds. Radiated signal
levels from the LENS are: during feedback 1*10-22 Watts/cm2
during baseline:
1*10-25 Watts/cm2.
LENS and placebo treatment are delivered as follows:
1. A LENS practitioner who is not involved with the participants in the study
creates a LENS High Efficiency
Sponsors
Universiteit Maastricht
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Ambulatory patients with ADHD (ADHD rating scale > 6/9).
Exclusion criteria
Exclusion criteria: Comorbidity on Axis 1 or 2 of DSM-IV-TR; relevant neurological disease, e.g., epilepsy; relevant neurovascular disease, e.g., status after CVA, migraine. Concurrent pharmacological treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in ADHD symptom level: clinical response defined as a decrease of at least 2 points on the self-reported ADHD rating scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. symptom levels of depression and anxiety (SCL-90 subscale scores) 2. global level of mental and physical functioning (SCL-90 total score) 3. sustained attention capacity: Bourdon-Wiersma task 4. inihibitory control: SSRT (inhibitory performance, response speed, individual response variability, and response accuracy; (Logan, Cowan et al. 1984) 5. medication use (agent, dosage) | — |
Countries
Netherlands
Outcome results
None listed